Innospec (IOSP)
(Delayed Data from NSDQ)
$112.28 USD
+2.22 (2.02%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $112.32 +0.04 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for Innospec Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,949 | 1,964 | 1,483 | 1,193 | 1,513 |
Cost Of Goods | 1,358 | 1,377 | 1,049 | 850 | 1,047 |
Gross Profit | 591 | 587 | 435 | 343 | 466 |
Selling & Adminstrative & Depr. & Amort Expenses | 430 | 399 | 303 | 309 | 316 |
Income After Depreciation & Amortization | 162 | 187 | 132 | 34 | 150 |
Non-Operating Income | 13 | -2 | 4 | 8 | 5 |
Interest Expense | 0 | 1 | 2 | 2 | 5 |
Pretax Income | 174 | 185 | 134 | 40 | 150 |
Income Taxes | 35 | 52 | 41 | 11 | 38 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 139 | 133 | 93 | 29 | 112 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 139 | 133 | 93 | 29 | 112 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 201 | 227 | 175 | 100 | 198 |
Depreciation & Amortization (Cash Flow) | 39 | 40 | 43 | 66 | 48 |
Income After Depreciation & Amortization | 162 | 187 | 132 | 34 | 150 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.02 | 24.98 | 24.85 | 24.78 | 24.73 |
Diluted EPS Before Non-Recurring Items | 6.09 | 6.04 | 4.80 | 3.22 | 5.22 |
Diluted Net EPS (GAAP) | 5.56 | 5.32 | 3.75 | 1.16 | 4.54 |
Fiscal Year end for Innospec Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 435.00 | 500.20 | 494.70 | 464.10 | 480.40 |
Cost Of Goods | 308.10 | 344.50 | 339.00 | 326.90 | 330.00 |
Gross Profit | 126.90 | 155.70 | 155.70 | 137.20 | 150.40 |
SG&A, R&D, and Dept/Amort Expenses | 86.20 | 105.20 | 111.20 | 95.30 | 116.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | 40.70 | 50.50 | 44.50 | 41.90 | 34.20 |
Non-Operating Income | 3.00 | 4.80 | 0.80 | 5.60 | 2.70 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 |
Pretax Income | 43.70 | 55.30 | 45.30 | 47.50 | 36.60 |
Income Taxes | 12.50 | 13.90 | 7.50 | 8.30 | 7.70 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 31.20 | 41.40 | 37.80 | 39.20 | 28.90 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 31.20 | 41.40 | 37.80 | 39.20 | 28.90 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 25.10 | 25.07 | 25.03 | 25.01 | 24.98 |
Diluted EPS Before Non-Recurring Items | 1.39 | 1.75 | 1.84 | 1.59 | 1.28 |
Diluted Net EPS (GAAP) | 1.24 | 1.65 | 1.50 | 1.57 | 1.16 |